Evoke Pharma Inc (EVOK)
4.89
-0.07
(-1.41%)
USD |
NASDAQ |
Dec 24, 13:00
4.89
0.00 (0.00%)
After-Hours: 13:59
Evoke Pharma Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| MEI Pharma Inc | 14.70M |
| Revance Therapeutics Inc | 23.29M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.8187M |
| Cash from Financing (Quarterly) | 2.980M |
| Free Cash Flow | -5.325M |
| Free Cash Flow Per Share (Quarterly) | -0.5848 |
| Free Cash Flow to Equity (Quarterly) | -0.8187M |
| Free Cash Flow Yield | -114.7% |